Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

[The different mechanism of the inhibition by buspirone and its camphorimide analogs of 5-HT3-serotoninergic effects].

Kharin NA, Abramets II, Komissarov IV, Samoĭlovich IM.

Biull Eksp Biol Med. 1993 Aug;116(8):167-9. Russian.

PMID:
7903873
2.

[The serotonin- and dopaminergic mechanisms in the action of 1-pyrimidinyl piperazine derivatives].

Abramets II, Obraztsova OG, Samoĭlovich IM, Kharin NA.

Eksp Klin Farmakol. 1992 May-Jun;55(3):8-11. Russian.

PMID:
1360856
4.

The effects of azapirones on serotonin1A neurons of the dorsal raphe.

Matheson GK, Pfeifer DM, Weiberg MB, Michel C.

Gen Pharmacol. 1994 Jul;25(4):675-83.

PMID:
7958728
5.
6.

[The GABA-ergic component of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives].

Abramets II, Talalaenko AN, Stakhovskiĭ IuV.

Eksp Klin Farmakol. 1992 Nov-Dec;55(6):5-7. Russian.

PMID:
1363956
8.

[Effects of serotonin-IA receptors on amino acid and dopaminergic responses of neurons].

Abramets II, Komissarov IV, Samoĭlovich IM.

Biull Eksp Biol Med. 1991 Dec;112(12):609-10. Russian.

PMID:
1777625
9.

S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.

Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, Spedding M, Brocco M.

J Pharmacol Exp Ther. 1997 Jul;282(1):148-61.

11.

[The correlation of the serotonin-positive and anxiolytic activities of nonbenzodiazepine substances].

Abramets II, Dolzhenko AT, Komissarov IV, Samoĭlovich IM, Talalaenko AN, Kharin NA.

Farmakol Toksikol. 1990 Sep-Oct;53(5):13-6. Russian.

PMID:
1979279
12.

5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.

Koenig JI, Meltzer HY, Gudelsky GA.

Pharmacol Biochem Behav. 1988 Apr;29(4):711-5.

PMID:
2901112
13.

Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.

Delgado M, Caicoya AG, Greciano V, Benhamú B, López-Rodríguez ML, Fernández-Alfonso MS, Pozo MA, Manzanares J, Fuentes JA.

Eur J Pharmacol. 2005 Mar 21;511(1):9-19.

PMID:
15777774
14.

Rigid analogues of buspirone and gepirone, 5-HT1A receptors partial agonists.

Chilmonczyk Z, Krajewski KJ, Cybulski J.

Farmaco. 2002 Nov;57(11):917-23.

PMID:
12484540
15.

[Effects of buspirone and buspirone-like 1-A-agonists of serotonin on the level of systemic blood pressure].

Komissarov IV, Mamonov AV, Filippov IT.

Biull Eksp Biol Med. 1991 Jul;112(7):62-4. Russian.

PMID:
1686564
16.

[Spinal ganglion neurons of rats--a model for the study of the central serotonin receptors].

Abramets II, Komissarov IV, Samoĭlovich IM.

Biull Eksp Biol Med. 1988 Aug;106(8):172-4. Russian.

PMID:
3416053
17.
18.

Modulation of frog spinal cord interneuronal activity by activation of 5-HT3 receptors.

Holohean AM, Hackman JC, Davidoff RA.

Brain Res. 1995 Dec 18;704(2):184-90.

PMID:
8788913
19.

Alnespirone and buspirone have anxiolytic-like effects in a conflict procedure in rats by stimulating 5-HT(1A) receptors.

Cervo L, Munoz C, Bertaglia A, Samanin R.

Behav Pharmacol. 2000 Apr;11(2):153-60.

PMID:
10877120
20.

Effects of repeated doses of azapirones on rat brain 5-HT1A receptors and plasma corticosterone levels.

Matheson GK, Raess BU, Tunnicliff G.

Gen Pharmacol. 1996 Mar;27(2):355-61.

PMID:
8919656
Items per page

Supplemental Content

Support Center